Adjuvant therapy of melanoma: is pegylated interferon alfa-2b what we've been waiting for?
- PMID: 18620932
- DOI: 10.1016/S0140-6736(08)61011-9
Adjuvant therapy of melanoma: is pegylated interferon alfa-2b what we've been waiting for?
Comment on
-
Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial.Lancet. 2008 Jul 12;372(9633):117-126. doi: 10.1016/S0140-6736(08)61033-8. Lancet. 2008. PMID: 18620949 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical